|Articles|June 10, 2022
NeurologyLive® Friday 5 — June 10, 2022
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 10, 2022.
Advertisement
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: State of Stem Cell Transplantation for Multiple Sclerosis
Jeffrey Cohen, MD, shared his perspective on the current use and study of stem cells for the treatment of multiple sclerosis, which he covered in the CMSC Presidential Lecture at the 2022 annual meeting.
2: Mind Moments™ Special Episode: Aducanumab and Anti-Amyloid-ß, One Year Later
Mind Moments™, a podcast from NeurologyLive®, brings you a special episode recap of aducanumab's journey from discovery to present, ahead of the June 2022 issue's in-depth cover story on the topic.
3: NeuroVoices: Jens Kuhle, MD, on Evobrutinib’s Association With Neurofilament Light Levels
The head of the MS Center at the University of Basel discussed an analysis presented at Consortium of MS Center’s Annual Meeting, focusing on the effects of BTK inhibitor evobrutinib on neurofilament light levels.
4: Peer Exchange: Multidisciplinary Management of OFF Episodes in PD
In Episode 10 of the NeurologyLive® Peer Exchange, "Considerations for the Maintenance of ON Time in Parkinson Disease," experts in movement disorders share the importance of multidisciplinary team collaboration for the management of OFF episodes and shared-decision making for treating Parkinson disease.
5: Lingering Challenges With Assessing, Treating Sleep Problems in Alzheimer Disease: Ruth Benca, MD, PhD
The professor and chair of Psychiatry & Human Behavior at Wake Forest School of Medicine discussed the need for improved tools to evaluate and treat sleep disorders in patients with Alzheimer disease.
—————————————————
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
3
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
4
NeurologyLive® Friday 5 — September 12, 2025
5